Praxis Precision Medicines Inc. (PRAX) secures analyst confidence after key FDA and trial wins

Praxis Precision Medicines Inc. (NASDAQ:PRAX) is one of the best 52-week high stocks to buy right now. Piper Sandler on ...

Praxis Precision Medicines: Latest Study Wins Sets Up 2 CNS Drug Approvals In 2026

Praxis Precision Medicines, Inc. soars after study success and pipeline wins. Explore key milestones, projections, and ...

Praxis Precision Medicines (PRAX) Gaining Confidence on EMBOLD Study Optimism

Praxis Precision Medicines, Inc. (NASDAQ:PRAX) is among the hidden multibagger stocks to invest in. It reported positive results from the registrational cohort of the EMBOLD study 4.

Praxis Precision Medicine's Options: A Look at What the Big Money is Thinking

But when something this big happens with PRAX, it often means somebody knows something is about to happen. So how do we know ...

Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

The 2024 Inducement Plan is used exclusively for the grant of equity awards to individuals who were not previously employees of Praxis, or following a bona fide period of non-employment, as an ...

Precision Aerospace & Defense Group, Inc. to Combine with FACT II Acquisition Corp. to Become Publicly Listed Company

Highlights Precision Aerospace & Defense Group, Inc. (“PAD”) to merge with FACT II Acquisition Corp. (NASDAQ: FACT) (“FACT”), creating a ...